Teva Pharmaceutical Industries Limited News Headlines

TEVA 
$57.4
*  
0.68
1.2%
Get TEVA Alerts
*Delayed - data as of Nov. 21, 2014  -  Find a broker to begin trading TEVA now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Biotech's 3 Most Influential CEOs
11/20/2014 10:20:03 AM - Motley Fool


Biogen Idec, PML Deaths, And Hemophilia Therapies
11/19/2014 3:01:00 PM - Seeking Alpha


Tracking George Soros's Portfolio - Q3 2014 Update
11/19/2014 5:48:00 AM - Seeking Alpha


The Passive DGI Portfolio: Quarterly Portfolio Update
11/18/2014 3:26:00 PM - Seeking Alpha


Personal Dividend Growth Portfolio Update: November 2014
11/18/2014 1:53:00 PM - Seeking Alpha


Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook
11/18/2014 1:00:00 PM - Investopedia


Why Mylan Will Continue To Soar
11/18/2014 9:50:00 AM - Seeking Alpha


Will Pfizer's Dividend Be Safe?
11/18/2014 9:29:02 AM - Motley Fool


Teva, Fedex Shares Look Fantastic, Arch Coal Headed Lower
11/17/2014 5:36:00 PM - TheStreet


Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for November 13, 2014
11/12/2014 9:00:04 AM - NASDAQ.com News


TEVA: Copaxone Patent Expiry Worries Are Overblown
11/11/2014 3:52:00 PM - Seeking Alpha


Are Expensive Biotech Drugs Bad For Business?
11/11/2014 10:45:00 AM - Seeking Alpha


Dividend Contenders, Future Champions Or Future Failures: Part 6
11/7/2014 6:13:00 PM - Seeking Alpha


Champions Oncology: Marking A Shift Toward Drug Discovery
11/7/2014 10:14:00 AM - Seeking Alpha


Teva Reports Positive Findings From QNASL Phase III Study In Children
11/7/2014 8:17:00 AM - RTT News


Actavis Beats on Q3 Earnings, Guides Above Expectations - Analyst Blog
11/5/2014 10:16:00 AM - Zacks.com


Actavis plc's Strong Third-Quarter Earnings Reflect Its Acquisition Bonanza
11/5/2014 9:36:26 AM - Motley Fool


Key Takeaways From Teva Pharmaceutical Industries Ltd.'s Third-Quarter Earnings
11/4/2014 6:35:46 PM - Motley Fool


Bristol-Myers Signs Option Deal to Acquire Galecto Biotech - Analyst Blog
11/4/2014 5:30:00 PM - Zacks.com


7 Good Stocks With Return Promise
11/2/2014 11:03:00 AM - Seeking Alpha


Teva Beats Q3 Earnings Expectations, Updates Outlook - Analyst Blog
10/31/2014 12:10:00 PM - Zacks.com


Is Mylan's Lively Third Quarter the Start of Something Special?
10/30/2014 8:51:32 PM - Motley Fool


Teva Q3 Profit Tops Estimates, Lifts Full-year EPS View
10/30/2014 9:35:00 AM - RTT News


Teva Q3 Profit Up, Lifts 2014 Adj. EPS View; Expands Share Buyback - Quick Facts
10/30/2014 7:23:00 AM - RTT News


Teva Pharmaceutical Industries Q3 14 Earnings Conference Call At 8:00 AM ET
10/30/2014 7:00:00 AM - RTT News